These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12456537)

  • 41. Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma.
    van den Berge M; Luijk B; Bareille P; Dallow N; Postma DS; Lammers JW
    Allergy; 2010 Dec; 65(12):1531-5. PubMed ID: 20560909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth and adrenal suppression due to moderate- to high-dose inhaled fluticasone.
    Chatzimichail A; Pietrobelli A; Boner AL
    J Paediatr Child Health; 2002 Dec; 38(6):623. PubMed ID: 12410884
    [No Abstract]   [Full Text] [Related]  

  • 43. [Growth and collagen synthesis disorders in asthmatic children treated with inhaled steroids].
    Martin-du Pan RC; Vonlanthen MC; Dubuis JM
    Rev Med Suisse Romande; 1999 Jun; 119(6):475-9. PubMed ID: 10422472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate.
    Kanda N; Yasuba H; Takahashi T; Mizuhara Y; Yamazaki S; Imada Y; Izumi Y; Kobayashi Y; Yamashita K; Kita H; Tamada T; Chiba T
    Am J Gastroenterol; 2003 Oct; 98(10):2146-8. PubMed ID: 14572559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Inhalational corticosteroids in COPD. THe ISOLDE Study (Inhaled Steroids in Obstructive Lung Disease in Europe)].
    Internist (Berl); 2001 Jul; 42(7):1050-2. PubMed ID: 11476049
    [No Abstract]   [Full Text] [Related]  

  • 46. Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment.
    Malerba M; Bossoni S; Radaeli A; Mori E; Bonadonna S; Giustina A; Tantucci C
    Chest; 2005 Feb; 127(2):515-21. PubMed ID: 15705990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β
    Devillier P; Humbert M; Boye A; Zachgo W; Jacques L; Nunn C; West S; Nicholls A; Antoun Z; Spinu L; Grouin JM
    Respir Med; 2018 Aug; 141():111-120. PubMed ID: 30053956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled steroids and asthma.
    Blaiss MS
    Pediatrics; 2002 Nov; 110(5):1030-1; author reply 1030-1. PubMed ID: 12415050
    [No Abstract]   [Full Text] [Related]  

  • 49. Fluticasone propionate in asthma: a long term dose comparison study.
    Verona E; Petrov D; Cserhati E; Hofman J; Geppe N; Medley H; Hughes S
    Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S; Rohatagi S; Williams J; Lloyd M; Kundu S; Banerji D
    Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Adrenal cortex function in children with bronchial asthma in fluticasone therapy].
    Hoffmann-Streb A; L'Allemand D; Niggemann B; Büttner P; Wahn U
    Monatsschr Kinderheilkd; 1993 Jun; 141(6):508-12. PubMed ID: 8336748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absorption of high-dose inhaled corticosteroids.
    Brutsche-Carlen M; Carlen-Brutsche I; Woodcock A
    Chest; 2000 May; 117(5):1526. PubMed ID: 10807856
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma.
    Rodrigo GJ
    Am J Respir Crit Care Med; 2005 Jun; 171(11):1231-6. PubMed ID: 15764724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis.
    Balfour-Lynn IM; Lees B; Hall P; Phillips G; Khan M; Flather M; Elborn JS;
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1356-62. PubMed ID: 16556691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends in the use of inhaled corticosteroids for childhood asthma in New Zealand.
    Johansson M; Hall J; Reith D; Jackson P; Tilyard M
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):483-7. PubMed ID: 12937871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of inhaled corticosteroids on bone density and metabolism.
    Woodcock A
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S456-9. PubMed ID: 9563372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of oral and inhaled corticosteroids on the hypothalamic-pituitary-adrenal axis.
    Lipworth BJ; Jackson CM
    J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):713-4. PubMed ID: 10482856
    [No Abstract]   [Full Text] [Related]  

  • 58. [Inhaled corticosteroids: first-line therapy in asthma].
    Hajiro T; Ishihara K
    Nihon Rinsho; 2001 Oct; 59(10):1967-72. PubMed ID: 11676140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
    Holliday SM; Faulds D; Sorkin EM
    Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Increased dosage of inhaled corticosteroids or addition of salmeterol in symptomatic asthma].
    Jébrak G
    Presse Med; 2000 Sep; 29(27):1512-3. PubMed ID: 11045121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.